---
title: Varicella Vaccine  attenuated
description: >-
  - Varicella vaccine is prescribed for the prevention of chickenpox
  (varicella), a highly contagious disease caused by the varicella-zoster virus
  (VZV).  It is also effective in preventing herpes zoster (shingles), a painful
  reactivation of VZV later in life. - **Pharmacological Classification:** ...
is_banned: false
lastModified: '2025-09-22T17:21:54.417Z'
faqs:
  - q: >-
      What is the recommended dosage for Varicella Vaccine attenuated?**

      **A:**  Children (12 months-12 years): 0.5 ml subcutaneously, two doses, 3
      months apart. Adults (≥13 years):  0.5 ml subcutaneously, two doses, 4-8
      weeks apart.
    a: >-
      A:**  Children (12 months-12 years): 0.5 ml subcutaneously, two doses, 3
      months apart. Adults (≥13 years):  0.5 ml subcutaneously, two doses, 4-8
      weeks apart.
  - q: |-
      Can pregnant women receive the varicella vaccine?**
      **A:** No, the varicella vaccine is contraindicated in pregnancy.
    a: 'A:** No, the varicella vaccine is contraindicated in pregnancy.'
  - q: >-
      What are the common side effects of the varicella vaccine?**

      **A:** Common side effects include pain, redness, swelling at the
      injection site, mild fever, and possibly a mild localized rash.
    a: >-
      A:** Common side effects include pain, redness, swelling at the injection
      site, mild fever, and possibly a mild localized rash.
  - q: >-
      How effective is the varicella vaccine?**

      **A:** Two doses of the vaccine are approximately 98% effective in
      preventing any form of varicella and almost 100% effective against severe
      disease.
    a: >-
      A:** Two doses of the vaccine are approximately 98% effective in
      preventing any form of varicella and almost 100% effective against severe
      disease.
  - q: >-
      Can the varicella vaccine be given to immunocompromised individuals?**

      **A:**  Generally no. The vaccine is contraindicated in individuals with
      severe immunodeficiency.  Consult a specialist for specific guidance.
    a: >-
      A:**  Generally no. The vaccine is contraindicated in individuals with
      severe immunodeficiency.  Consult a specialist for specific guidance.
  - q: >-
      What is the interval between doses for the varicella vaccine?**

      **A:** For children (12 months-12 years), the interval is at least 3
      months. For adults (≥13 years), it's 4-8 weeks.
    a: >-
      A:** For children (12 months-12 years), the interval is at least 3 months.
      For adults (≥13 years), it's 4-8 weeks.
  - q: |-
      Can the varicella vaccine be given with other vaccines?**
      **A:** Yes, it can be administered concurrently with other vaccines.
    a: 'A:** Yes, it can be administered concurrently with other vaccines.'
  - q: >-
      What should be done if a dose of varicella vaccine is missed?**

      **A:** Administer the missed dose as soon as possible. There's no need to
      restart the series.
    a: >-
      A:** Administer the missed dose as soon as possible. There's no need to
      restart the series.
  - q: >-
      Does the varicella vaccine completely eliminate the risk of shingles?**

      **A:** No, it reduces the risk of shingles and its severity but does not
      eliminate it completely.
    a: >-
      A:** No, it reduces the risk of shingles and its severity but does not
      eliminate it completely.
---
## **Usage**

- Varicella vaccine is prescribed for the prevention of chickenpox (varicella), a highly contagious disease caused by the varicella-zoster virus (VZV).  It is also effective in preventing herpes zoster (shingles), a painful reactivation of VZV later in life.
- **Pharmacological Classification:** Vaccine (Live attenuated viral vaccine).
- **Mechanism of Action:** The vaccine contains a weakened, live form of the varicella-zoster virus. Upon administration, the virus replicates, triggering an immune response without causing the full-blown disease. This generates immunological memory, protecting against future VZV infections.

## **Alternate Names**

- Varicella vaccine live
- Chickenpox vaccine
- **Brand Names:**
    - Varivax®
    - ProQuad® (combined MMRV vaccine)


## **How It Works**

- **Pharmacodynamics:**  The vaccine mimics a natural varicella infection but on a much smaller scale. The attenuated virus replicates within the body, stimulating both humoral (antibody-mediated) and cell-mediated immunity.  This leads to the production of antibodies and specific T-cells that can neutralize VZV upon subsequent exposure.

- **Pharmacokinetics:**
    - **Absorption:** The vaccine is administered subcutaneously, where it is gradually absorbed into the bloodstream.
    - **Metabolism:** The virus replicates within the body, primarily in the lymphatic system. The immune system eliminates the attenuated virus over time.
    - **Excretion:** Viral particles and their components are eliminated through multiple routes, including urine and feces.

- **Mode of Action:** The vaccine triggers the adaptive immune response.  Antigen-presenting cells process viral antigens and present them to lymphocytes, leading to activation of B cells and T cells specific for VZV.  Activated B cells differentiate into plasma cells, producing antibodies that neutralize the virus.  Cytotoxic T lymphocytes are also activated, contributing to the elimination of infected cells.

- **Receptor Binding/Enzyme Inhibition:** The vaccine's mechanism primarily involves activating the adaptive immune response, rather than direct receptor binding or enzyme inhibition. It relies on activating the immune system to produce antibodies and cytotoxic T cells to counteract the varicella virus.

- **Elimination Pathways:** The attenuated virus and viral components are eliminated through multiple pathways including the lymphatic system and via renal and hepatic routes. 


## **Dosage**

### **Standard Dosage**

#### **Adults (≥13 years):**

- 0.5 ml subcutaneously administered as two doses, 4 to 8 weeks apart. ProQuad® (MMRV) is *not* approved for this age group.

#### **Children (12 months - 12 years):**

- 0.5 ml subcutaneously administered as two doses, separated by at least 3 months.
- MMRV (ProQuad®) is approved for this age group and may be preferred for the second dose (15 months-12 years) and first dose at ≥48 months.
- For the first dose (12–47 months), MMR and varicella vaccines are generally given separately unless the parent or caregiver prefers MMRV.

#### **Special Cases:**

- **Elderly Patients:** Standard adult dosage.
- **Patients with Renal Impairment:**  No dose adjustment is typically necessary.
- **Patients with Hepatic Dysfunction:** No dose adjustment is typically necessary.
- **Patients with Comorbid Conditions:** Use with caution in immunocompromised individuals. Consult specialist advice if needed.

### **Clinical Use Cases**

Varicella vaccine is primarily used for *prevention*, not treatment, hence its use in the following scenarios is not applicable:

- **Intubation:** Not applicable.
- **Surgical Procedures:** Not applicable.
- **Mechanical Ventilation:** Not applicable.
- **Intensive Care Unit (ICU) Use:** Not applicable.
- **Emergency Situations:** Not applicable.


### **Dosage Adjustments**

- Immunosuppressed individuals: Varicella vaccine is generally contraindicated for individuals with severe immunodeficiency.

## **Side Effects**

### **Common Side Effects:**

- Pain, redness, or swelling at the injection site.
- Mild fever.
- A small number of individuals (around 5%) may develop a mild, localized varicella-like rash 5-26 days post-vaccination.

### **Rare but Serious Side Effects:**

- Severe allergic reaction (anaphylaxis).
- Pneumonia.
- Encephalitis.

### **Long-Term Effects:**

- Herpes zoster (shingles) may still occur, though at a reduced incidence and severity compared to unvaccinated individuals.

### **Adverse Drug Reactions (ADR):**

- Thrombocytopenia (low platelet count).
- Disseminated varicella (rare in healthy individuals, primarily seen in immunocompromised).


## **Contraindications**

- Pregnancy.
- Severe immunodeficiency (e.g., leukemia, lymphoma, congenital immunodeficiency).
- Active, untreated tuberculosis.
- Current moderate or severe illness with or without fever.
- Allergy to any component of the vaccine, including gelatin or neomycin.

## **Drug Interactions**

- **Immunosuppressants:** Avoid concurrent administration.
- **Salicylates:** Should be avoided for 6 weeks after vaccination due to a theoretical increased risk of Reye's syndrome.
- **Recent blood transfusion:**  Postpone vaccination for at least 3 months.


## **Pregnancy and Breastfeeding**

- **Pregnancy Safety Category:**  Contraindicated.
- **Fetal Risks:**  Potential risk of congenital varicella syndrome if infected with wild-type VZV during pregnancy. However, the vaccine itself is contraindicated.
- **Breastfeeding:** Caution advised. Limited data are available.  

## **Drug Profile Summary**

- **Mechanism of Action:** Live attenuated viral vaccine stimulating immune response to VZV.
- **Side Effects:** Injection site reactions, fever, mild rash, rarely serious complications.
- **Contraindications:** Pregnancy, immunodeficiency, active tuberculosis.
- **Drug Interactions:** Immunosuppressants, salicylates.
- **Pregnancy & Breastfeeding:** Contraindicated in pregnancy.
- **Dosage:** 0.5ml SC x 2 doses; 3 months apart for children, 4-8 weeks apart for adults.


## **Popular Combinations**

- MMRV (Measles, Mumps, Rubella, and Varicella) combined vaccine.

## **Precautions**

- **General Precautions:** Assess immune status. Postpone vaccination in individuals with moderate or severe illness.  Monitor for allergic reactions.
- **Specific Populations:** Standard precautions as mentioned above.
- **Lifestyle Considerations:**  No specific lifestyle considerations.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Varicella Vaccine attenuated?**
**A:**  Children (12 months-12 years): 0.5 ml subcutaneously, two doses, 3 months apart. Adults (≥13 years):  0.5 ml subcutaneously, two doses, 4-8 weeks apart.


### **Q2: Can pregnant women receive the varicella vaccine?**
**A:** No, the varicella vaccine is contraindicated in pregnancy.


### **Q3: What are the common side effects of the varicella vaccine?**
**A:** Common side effects include pain, redness, swelling at the injection site, mild fever, and possibly a mild localized rash.


### **Q4: How effective is the varicella vaccine?**
**A:** Two doses of the vaccine are approximately 98% effective in preventing any form of varicella and almost 100% effective against severe disease.

### **Q5: Can the varicella vaccine be given to immunocompromised individuals?**
**A:**  Generally no. The vaccine is contraindicated in individuals with severe immunodeficiency.  Consult a specialist for specific guidance.


### **Q6:  What is the interval between doses for the varicella vaccine?**
**A:** For children (12 months-12 years), the interval is at least 3 months. For adults (≥13 years), it's 4-8 weeks.


### **Q7: Can the varicella vaccine be given with other vaccines?**
**A:** Yes, it can be administered concurrently with other vaccines.


### **Q8: What should be done if a dose of varicella vaccine is missed?**
**A:** Administer the missed dose as soon as possible. There's no need to restart the series.



### **Q9: Does the varicella vaccine completely eliminate the risk of shingles?**
**A:** No, it reduces the risk of shingles and its severity but does not eliminate it completely.
